Literature DB >> 11954876

Clinically asymptomatic axial disease in psoriatic spondyloarthropathy. A retrospective study.

R Queiro1, J Belzunegui, C González, Dios J R De, C Sarasqueta, J C Torre, M Figueroa.   

Abstract

The aim of this study was to analyse retrospectively the prevalence and the clinical features of clinically asymptomatic axial involvement in patients with psoriasis and axial radiological features of spondyloarthropathy (PsSpA). We performed a cross-sectional study based on the clinical records of 70 patients, 44 men and 26 women, with a mean age of 48.7+/-14.2 years. PsSpA was defined by the presence of radiographic sacroiliitis (SI) greater than or equal to grade 2, and/or any other typical radiological sign of spondylitis in patients with psoriasis. When the radiological signs were present in the absence of inflammatory back pain and/or buttock pain, patients were grouped as having asymptomatic axial disease. HLA-B27 was determined by serological methods in the 70 patients and in 82 healthy controls from our general population. Fourteen patients (20%), 11 with radiological SI, two with facet joint erosion-fusion and one with aseptic discitis, showed no evidence of symptomatic spinal disease. Twenty-nine patients (41%) showed cervical spine disease (CSD), but only 17 of them (58.6%) had pain and rigidity at this level, whereas 12 (41.4%) did not show clinical symptoms. CSD was associated with duration of arthritis (P = 0.043) and peripheral erosions (P = 0.037). HLA-B27 correlated well with bilateral SI (P = 0.002) and PsSpA (P<0.0004, RR 6.4), but showed no association with unilateral SI nor with syndesmophytes or asymptomatic disease. Univariate analysis demonstrated associations between symptomatic disease and longer duration of arthritis (P = 0.041) and higher IgM values (P = 0.05). There is a high prevalence of asymptomatic involvement in patients with PsSpA The significance of these asymptomatic changes is not known, but they probably represent a common characteristic of spondyloarthropathies rather than a specific feature associated with psoriasis.

Entities:  

Mesh:

Year:  2002        PMID: 11954876     DOI: 10.1007/s100670200003

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis.

Authors:  Gamze Kılıç; Erkan Kılıç; Kemal Nas; Murat Karkucak; Erhan Çapkın; Abdullah Zübeyir Dağlı; Remzi Çevik; Salih Özgöçmen
Journal:  Clin Rheumatol       Date:  2014-07-02       Impact factor: 2.980

2.  Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real life.

Authors:  Sibel Zehra Aydin; Orhan Kucuksahin; Levent Kilic; Atalay Dogru; Ozun Bayindir; Cem Ozisler; Ahmet Omma; Emine Figen Tarhan; Abdulsamet Erden; Gezmis Kimyon; Meryem Can; Ediz Dalkilic; Sule Yavuz; Sibel Bakirci Ureyen; Esen Kasapoglu Gunal; Fatıma Arslan Alhussain; Lutfi Akyol; Ayse Balkarli; Sema Yilmaz; Muhammet Cinar; Muge Tufan Aydin; Dilek Solmaz; Ridvan Mercan; Sukran Erten; Umut Kalyoncu
Journal:  Clin Rheumatol       Date:  2018-06-13       Impact factor: 2.980

3.  Sacroiliac joint involvement in psoriasis.

Authors:  Cahit Kaçar; Ilhan Sezer; Hilal Kocabaş; Hasan Fatih Cay; Can Cevikol; Erkan Alpsoy; Meltem Alkan Melikoğlu; Ayşe Akman
Journal:  Rheumatol Int       Date:  2010-03-31       Impact factor: 2.631

Review 4.  Looking into the new ASAS classification criteria for axial spondyloarthritis through the other side of the glass.

Authors:  Nurullah Akkoc; Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

5.  Evaluation of spinal mobility measurements in predicting axial psoriatic arthritis.

Authors:  Ying-ying Leung; Kwok Wah Ho; Lai Shan Tam; Tracy Y Zhu; Lai W Kwok; Tena K Li; Emily W Kun; Edmund K Li
Journal:  Clin Rheumatol       Date:  2011-03-03       Impact factor: 2.980

Review 6.  Imaging in psoriatic arthritis.

Authors:  Allen Anandarajah
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

Review 7.  Psoriatic arthritis: a critical review.

Authors:  Varun Dhir; Amita Aggarwal
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

Review 8.  MRI in psoriatic arthritis: insights into pathogenesis and treatment response.

Authors:  Fiona M McQueen; Nicola Dalbeth; Anthony Doyle
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

9.  Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria.

Authors:  Hernán Maldonado Ficco; Gustavo Citera; José Antonio Maldonado Cocco
Journal:  Clin Rheumatol       Date:  2014-05-08       Impact factor: 2.980

Review 10.  ASAS classification criteria for axial spondyloarthritis: time to modify.

Authors:  Nurullah Akkoc; Muhammad A Khan
Journal:  Clin Rheumatol       Date:  2016-04-19       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.